PD-L1 Expression in Gliomas: A Potential Immunotherapeutic Target in High-grade Tumours
{{output}}
Gliomas are the most common primary tumours of the central nervous system, with glioblastoma (grade 4 glioma) being the most malignant form. Despite standard therapy, patient survival remains poor. Immune checkpoint blockade targeting the PD-1/PD-L1 axis has s... ...
